Clofarabins farmakokinetik blev undersøgt hos 40 patienter mellem 2 og 19 år med recidiverende eller refraktær ALL eller AML.
The pharmacokinetics of clofarabine were studied in 40 patients aged between 2 to 19 years old with relapsed or refractory ALL or AML.